Press release
Leading Companies Reinforce Their Presence in the Myocardial Infarction Market
Myocardial Infarction Market
Forecasted Growth and Market Size of the Myocardial Infarction Industry
The myocardial infarction market is anticipated to expand significantly, reaching a valuation of $3.15 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 7.5%. Several factors contribute to this optimistic outlook, including advancements in cardiac drug formulations, wider adoption of telecardiology services, increased funding directed toward cardiology research and development, greater utilization of artificial intelligence for cardiac diagnosis, and the expansion of emergency cardiac care infrastructure. Key trends expected to influence the market include a rising focus on advanced cardiac rehabilitation programs, the growing use of combination drug therapies for post-myocardial infarction care, heightened attention on early detection and prevention, a broader application of minimally invasive procedures in acute myocardial infarction management, and an emphasis on lifestyle changes to reduce long-term risks.
Download a free report of the myocardial infarction market report:
https://www.thebusinessresearchcompany.com/report/myocardial-infarction-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Primary Companies Leading the Myocardial Infarction Market
The myocardial infarction market comprises several leading pharmaceutical and biotech firms driving innovation and treatment availability. Some of the dominant players include Pfizer Inc, Johnson & Johnson Services Inc, Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Boehringer Ingelheim GmbH, Daiichi Sankyo Co Ltd, Apotex Inc, Par Pharmaceutical Companies Inc, Amgen Inc, Merck & Co Inc, Takeda Pharmaceutical Company Ltd, Gilead Sciences Inc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddy's Laboratories Ltd, Lupin Ltd, United Therapeutics Corporation, CSPC Pharmaceutical Group Ltd, Zhejiang Huahai Pharmaceutical Co Ltd, Qilu Pharmaceutical Co Ltd, and Chia Tai Tianqing Pharmaceutical Group Co Ltd.
Significant Acquisition Enhances Cardiovascular Portfolio
In March 2024, Novo Nordisk, a Denmark-based company specializing in therapies for diabetes and cardiovascular diseases, acquired Cardior Pharmaceuticals for approximately €1.025 billion (about $1.11 billion). This strategic acquisition aims to strengthen Novo Nordisk's cardiovascular offerings by incorporating advanced RNA-targeting treatments. It also accelerates the development of a novel therapy designed for managing post-myocardial infarction heart failure. Cardior Pharmaceuticals, headquartered in Germany, focuses on RNA-based therapeutics, with its leading candidate CDR132L targeting microRNA for heart failure treatment following myocardial infarction.
View the full myocardial infarction market report:
https://www.thebusinessresearchcompany.com/report/myocardial-infarction-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Technological Trends in Cardiac Care
Innovation in the myocardial infarction and related medical device markets is rapidly evolving, with companies emphasizing the development of advanced tools to improve surgical precision and patient outcomes. One notable advancement is the integration of navigation-enabled instruments that streamline surgical workflows. These systems combine sophisticated implants with instruments designed to seamlessly work with enabling technologies, addressing complex cardiovascular and spine conditions more effectively.
For instance, in April 2024, DePuy Synthes introduced the TriALTIS Spine System, a next-generation posterior thoracolumbar pedicle screw system. This new product portfolio, coupled with advanced instrumentation compatible with power and navigation technologies, aims to meet unmet clinical needs. The TriALTIS system supports surgeons in achieving consistent results when treating complex spinal issues such as degenerative diseases, tumors, trauma, and deformities.
Detailed Segmentation of the Global Myocardial Infarction Market
This report breaks down the myocardial infarction market into key segments for a comprehensive understanding:
1) Drug Class: Antiplatelet Agents, Glycoprotein IIb or IIIa Inhibitors, Antithrombotic Agents, Beta-Adrenergic Blockers, Vasodilators, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin-Receptor Blockers, Analgesics, and Thrombolytics
2) Route of Administration: Oral, Injectable
3) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Further subcategories for drug classes include:
- Antiplatelet Agents such as Aspirin, Clopidogrel, Ticagrelor
- Glycoprotein IIb or IIIa Inhibitors including Abciximab, Eptifibatide, Tirofiban
- Antithrombotic Agents like Heparins and Direct Oral Anticoagulants (DOACs)
- Beta-Adrenergic Blockers such as Metoprolol and Carvedilol
- Vasodilators including Nitroglycerin and Isosorbide Dinitrate
- ACE Inhibitors like Lisinopril and Enalapril
- Angiotensin-Receptor Blockers such as Losartan and Valsartan
- Analgesics including Morphine and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Thrombolytics such as Alteplase and Reteplase
These classifications provide a detailed picture of the product landscape, administration methods, and channels through which therapies reach patients in the myocardial infarction treatment space.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Reinforce Their Presence in the Myocardial Infarction Market here
News-ID: 4483470 • Views: …
More Releases from The Business Research Company
Future Perspectives: Key Trends Shaping the Narcolepsy Drugs Market Until 2030
A growing focus on neurological health and advancements in pharmaceutical research are setting the stage for a significant expansion in the narcolepsy drugs market. As awareness and diagnosis rates increase worldwide, new treatment options are emerging to improve patient outcomes. Below is a detailed overview of the market's size, key drivers, leading companies, and important segments shaping its future.
Steady Market Growth Expected in the Narcolepsy Drugs Sector
The narcolepsy drugs…
In-Depth Examination of Segments, Industry Trends, and Key Players in the Myopia …
The myopia treatment market is on track for substantial expansion in the coming years, driven by advances in technology and increasing awareness of eye health. Growing interest in effective myopia management and evolving treatment options are positioning this sector for remarkable growth by 2030. Let's explore the current market size, key players, trends, and segmentation shaping this dynamic industry.
Projected Market Size and Growth of the Myopia Treatment Market
The myopia…
Emerging Growth Trends Driving Expansion in the Mycobacterium Tuberculosis Marke …
The Mycobacterium tuberculosis market is gaining increasing attention due to ongoing advancements in diagnostic technologies and growing efforts to control tuberculosis globally. With expanding use of innovative tools and rising healthcare initiatives, this sector is expected to experience consistent growth in the coming years. Let's explore the market size projections, influential companies, current trends, and key segments shaping its future.
Projected Growth and Market Size of the Mycobacterium Tuberculosis Market
The…
An Overview of Segmentation, Market Dynamics, and Competitive Landscape in the M …
The muscle pain treatment market is on a promising growth trajectory, driven by advances in medical formulations and an increasing focus on personalized care. As awareness and options for managing muscle pain expand, the market is set to experience significant development over the coming years. Below, we explore the market's size, key players, trends, and segmentation to understand its current dynamics and future outlook.
Projected Expansion of the Muscle Pain Treatment…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
